SS-31, also known by the developmental name Elamipretide, is a synthetic tetrapeptide with a well-defined sequence: D-Arg-Dmt-Lys-Phe-NH2. That shorthand points to four amino acids joined in a specific order, with the second residue being 2′,6′-dimethyltyrosine (Dmt), a non-standard amino acid that gives the molecule some of its distinctive chemical character. SS-31 belongs to a class of mitochondria-targeted peptides sometimes called Szeto-Schiller peptides, named after the researchers who characterized the series. The compound draws sustained attention in preclinical research because it interacts selectively with the inner mitochondrial membrane — an organelle compartment that sits at the center of cellular energy metabolism and stress signaling.
Molecular Structure and Key Properties
SS-31 has a molecular weight of approximately 639 daltons, which places it firmly in the low-molecular-weight peptide category. Its sequence alternates between aromatic and basic residues, a pattern that appears to drive the compound’s affinity for cardiolipin — a phospholipid found almost exclusively in the inner mitochondrial membrane. The Dmt residue contributes electron-donating properties due to its methyl-substituted aromatic ring, and the overall charge of the molecule at physiological pH is cationic. This combination of features — a positive charge, aromatic scavenging capacity, and specific lipid-binding affinity — makes SS-31 a structurally distinctive tool for researchers studying membrane-associated biochemistry. In laboratory settings, the compound is typically supplied as the acetate or trifluoroacetate salt and prepared as aqueous stock solutions for in vitro use.
Research Applications
The primary research application for SS-31 involves studying mitochondrial membrane dynamics and the downstream consequences of cardiolipin interaction. Cardiolipin plays a structural role in organizing electron transport chain complexes — the protein assemblies that drive ATP synthesis inside mitochondria — and researchers use SS-31 as a tool to probe how cardiolipin integrity affects those complexes under stress conditions. In cell-based models, studies have examined SS-31’s effects on mitochondrial membrane potential, reactive oxygen species (ROS) production, and cytochrome c release, the last of which is a marker researchers track in models of apoptosis.
Preclinical animal work has extended these observations into models of ischemia-reperfusion injury, in which tissues are deprived of oxygen and then re-oxygenated — a process that generates significant oxidative stress. Researchers have also applied SS-31 in models of cardiomyopathy, renal tubular cell stress, and age-associated mitochondrial dysfunction. In each context, the compound functions as a research probe rather than a defined therapeutic: investigators use it to ask questions about what happens when cardiolipin organization is preserved or disrupted during a particular stressor. Measures of ATP production, mitochondrial respiration rates, and cellular viability endpoints are common readouts across these study designs.
Analytical Use and Sourcing Considerations
Because SS-31 contains a non-standard amino acid and an amidated C-terminus, synthesis quality matters considerably. Research protocols typically require purity of 95% or greater, confirmed by high-performance liquid chromatography (HPLC). Mass spectrometry verification is standard practice for identity confirmation, particularly when the compound will be used in mechanistic studies where off-target effects from impurities could confound results. Researchers should also request a certificate of analysis that documents both the counterion form and residual solvent content.
SS-31 is reasonably stable when stored as a lyophilized powder under inert conditions at low temperature, but repeated freeze-thaw cycles of reconstituted solutions degrade the compound over time. Working aliquots should be prepared at appropriate concentrations and used promptly. When evaluating suppliers, research coordinators should confirm that synthesis is performed under GMP-compliant or validated analytical conditions and that batch-to-batch consistency is documented. The peptide’s acetate versus trifluoroacetate salt form can affect certain biological assays, so counterion specification at the point of procurement is an important practical detail.
SS-31 continues to attract research interest because it offers a structurally specific handle on cardiolipin biology and mitochondrial membrane function — two areas that remain active frontiers in cell biology and metabolic disease research.
For Research Use Only. Not for human consumption. All compounds described in this article are supplied as analytical-grade reagents for institutional in vitro laboratory research only. Not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
